about
Increased vigilance needed for the detection of thrombotic complications of central venous access in adolescent cystic fibrosis patientsA case report of primary ciliary dyskinesia, laterality defects and developmental delay caused by the co-existence of a single gene and chromosome disorder.Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosisDietary Nitrate Acutely and Markedly Increased Exhaled Nitric Oxide in a Cystic Fibrosis Case.Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?Vitamin D as an adjunctive therapy in asthma. Part 1: A review of potential mechanisms.Vitamin D as an adjunctive therapy in asthma. Part 2: A review of human studies.Vitamin D3 for uncontrolled childhood asthma: A pilot study.Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective Study.Vitamin D receptor variants and uncontrolled asthma.Differentiation of the peripherally mediated from the centrally mediated influences of adenosine in the rat during systemic hypoxia.Blunted serum 25(OH)D response to vitamin D supplementation in children with autismHigh concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrationsVitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosisPostnatal development of the pattern of respiratory and cardiovascular response to systemic hypoxia in the piglet: the roles of adenosineMethicillin-resistant Staphylococcus aureus (Panton-Valentine leucocidin) cavitating pneumonia in a healthy childNight blindness in a teenager with cystic fibrosis
P50
Q26829250-52A631D2-46B7-4CD8-9B95-C8B1A1200777Q35678026-E2F0A0FB-A0E8-4946-A91B-29B6F29A7229Q35947593-288F35AB-0385-45C9-9540-50A8725D1C15Q37636155-C169EF3F-6CB7-4298-ABB3-F79C9FD27B23Q38057771-AD4D3035-B247-42E7-9E65-F30E30DCDF9DQ38366880-0541C572-EC48-44F0-A625-1984DB4E2560Q38370026-2078E599-D25E-4B08-A6FA-5B9088DB6946Q40023712-06002E69-DDEE-4BC7-A5A8-AD53675E47E1Q40530210-3C39FDAF-46D9-49EE-A924-D2616535584FQ47642926-F31A7434-9472-4FE7-AF73-E05F8A3CC642Q54196486-53E88BBB-A891-42C4-939A-BE4D319CE9C5Q57285720-BCB3289A-5633-4D60-A73B-EBA48742492AQ60056981-5C45AF50-9BB3-4D4F-97DD-B0BD168F4110Q60056983-BE63E666-8191-4F3D-AB84-FDE0FC8038BCQ73037387-5CEFDA75-F01D-4EF7-A88C-C59DD7F47258Q84460325-FE983009-EE72-4AD1-8085-CEA62160E061Q85016703-2DABB6E6-0602-4648-80B7-B1B83E3DD408
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Basil Elnazir
@ast
Basil Elnazir
@en
Basil Elnazir
@es
Basil Elnazir
@nl
type
label
Basil Elnazir
@ast
Basil Elnazir
@en
Basil Elnazir
@es
Basil Elnazir
@nl
prefLabel
Basil Elnazir
@ast
Basil Elnazir
@en
Basil Elnazir
@es
Basil Elnazir
@nl
P106
P1153
26532671600
P31
P496
0000-0001-8794-5100